These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties. Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329 [TBL] [Abstract][Full Text] [Related]
11. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. Alkondon M; Albuquerque EX J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571 [TBL] [Abstract][Full Text] [Related]
13. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK J Pharmacol Exp Ther; 1997 Jan; 280(1):384-92. PubMed ID: 8996219 [TBL] [Abstract][Full Text] [Related]
14. Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats. Sacaan AI; Menzaghi F; Dunlop JL; Correa LD; Whelan KT; Lloyd GK J Pharmacol Exp Ther; 1996 Feb; 276(2):509-15. PubMed ID: 8632316 [TBL] [Abstract][Full Text] [Related]
15. Attentional effects of nicotinic agonists in rats. Hahn B; Sharples CG; Wonnacott S; Shoaib M; Stolerman IP Neuropharmacology; 2003 Jun; 44(8):1054-67. PubMed ID: 12763099 [TBL] [Abstract][Full Text] [Related]
16. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans. Rodrigues AD; Ferrero JL; Amann MT; Rotert GA; Cepa SP; Surber BW; Machinist JM; Tich NR; Sullivan JP; Garvey DS Drug Metab Dispos; 1994; 22(5):788-98. PubMed ID: 7530622 [TBL] [Abstract][Full Text] [Related]
17. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Decker MW; Curzon P; Brioni JD; Arnerić SP Eur J Pharmacol; 1994 Aug; 261(1-2):217-22. PubMed ID: 8001648 [TBL] [Abstract][Full Text] [Related]
18. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach. Grupe M; Grunnet M; Bastlund JF; Jensen AA Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):187-200. PubMed ID: 25441336 [TBL] [Abstract][Full Text] [Related]
19. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Kox M; van Velzen JF; Pompe JC; Hoedemaekers CW; van der Hoeven JG; Pickkers P Biochem Pharmacol; 2009 Oct; 78(7):863-72. PubMed ID: 19576181 [TBL] [Abstract][Full Text] [Related]